A/Prof John Amerena

Experts / A/Prof John Amerena

A/Prof John Amerena

Cardiologist; Appoints at Medical School, Deakin University

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

By A/Prof John Amerena

Monographs

Cardiology

A/Prof John Amerena

Cardiologist; Appoints at Medical School, Deakin University

More from this expert

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.

A/Prof John Amerena

Cardiologist; Appoints at Medical School, Deakin University

More from this expert

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.